MUTUAL PHARMACEUTICAL COMPANY/AR SCIENTIFIC LAUNCHES QUALAQUIN (QUININE SULFATE CAPSULES USP, 324 MG)

Mutual Pharmaceutical Company/AR Scientific announced the commercial introduction of QUALAQUIN (quinine sulfate capsules USP, 324 mg) for the treatment of uncomplicated Plasmodium falciparum malaria. QUALAQUIN is the first and only formulation of quinine sulfate to be evaluated and approved by the U.S. Food and Drug Administration (FDA). QUALAQUIN has been designated an orphan drug by the FDA. Yahoo Finance (http://biz.yahoo.com/prnews/060712/nyw082.html?.v=54)